Legend Biotech Corp
LEGN39.455USD
+1.965+5.24%
Fechamento 07/09, 16:00（ET）Cotações atrasadas em 15 min
7.26BValor de mercado
PerdaP/L TTM
Mais detalhes de Legend Biotech Corp Empresa
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Informações da empresa
Código da empresaLEGN
Nome da EmpresaLegend Biotech Corp
Data de listagemJun 04, 2020
Fundado em2015
CEODr. Ying Huang, Ph.D.
Número de funcionários2600
Tipo de títulosDepository Receipt
Fim do ano fiscalJun 04
Endereço2101 Cottontail Lane
CidadeSOMERSET
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal08873
Telefone17328505598
Sitehttps://investors.legendbiotech.com/
Código da empresaLEGN
Data de listagemJun 04, 2020
Fundado em2015
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
84.32K
--
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
7.62K
--
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Ms. Jessie Yeung
Ms. Jessie Yeung
Interim Chief Financial Officer, Director
Interim Chief Financial Officer, Director
--
--
Dr. Peter Salovey, Ph.D.
Dr. Peter Salovey, Ph.D.
Independent Director
Independent Director
--
--
Mr. Wai Man (Philip) Yau, CPA
Mr. Wai Man (Philip) Yau, CPA
Independent Director
Independent Director
--
--
Dr. Ying Huang, Ph.D.
Dr. Ying Huang, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
-100.00%
Mr. Tomas J. (Tom) Heyman, Jr.
Mr. Tomas J. (Tom) Heyman, Jr.
Independent Director
Independent Director
--
--
Dr. Fangliang (Frank) Zhang, Ph.D.
Dr. Fangliang (Frank) Zhang, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
84.32K
--
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
7.62K
--
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Ms. Jessie Yeung
Ms. Jessie Yeung
Interim Chief Financial Officer, Director
Interim Chief Financial Officer, Director
--
--
Dr. Peter Salovey, Ph.D.
Dr. Peter Salovey, Ph.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
168.29M
86.28%
Europe
26.67M
13.67%
China
90.00K
0.05%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: há 9 horas
Atualizado em: há 9 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
6.11%
Westfield Capital Management Company, L.P.
3.75%
T. Rowe Price Associates, Inc.
3.65%
HHLR Advisors, Ltd.
3.25%
Suvretta Capital Management, LLC
2.03%
Other
81.21%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
6.11%
Westfield Capital Management Company, L.P.
3.75%
T. Rowe Price Associates, Inc.
3.65%
HHLR Advisors, Ltd.
3.25%
Suvretta Capital Management, LLC
2.03%
Other
81.21%
Tipos de investidores
Investidores
Proporção
Investment Advisor
19.22%
Investment Advisor/Hedge Fund
18.32%
Hedge Fund
8.47%
Research Firm
1.51%
Corporation
1.22%
Venture Capital
0.50%
Bank and Trust
0.40%
Pension Fund
0.13%
Insurance Company
0.09%
Other
50.14%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
544
92.22M
50.04%
-25.07M
2025Q1
566
91.15M
49.68%
-26.78M
2024Q4
546
104.37M
56.89%
-4.12M
2024Q3
521
96.19M
52.43%
-11.10M
2024Q2
501
96.66M
52.77%
-1.31M
2024Q1
490
91.55M
50.22%
-3.47M
2023Q4
482
91.08M
50.06%
-4.11M
2023Q3
468
90.50M
49.93%
-2.81M
2023Q2
459
88.99M
49.23%
+9.84M
2023Q1
421
72.14M
43.70%
-3.07M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
11.26M
6.11%
-452.89K
-3.87%
Mar 31, 2025
Westfield Capital Management Company, L.P.
6.92M
3.75%
+1.20M
+21.07%
Mar 31, 2025
T. Rowe Price Associates, Inc.
6.73M
3.65%
-78.41K
-1.15%
Mar 31, 2025
HHLR Advisors, Ltd.
5.98M
3.25%
--
--
Mar 31, 2025
Suvretta Capital Management, LLC
3.75M
2.03%
+253.73K
+7.26%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.11M
1.69%
-148.24K
-4.55%
Mar 31, 2025
Braidwell LP
2.98M
1.62%
--
--
Mar 31, 2025
Invesco Advisers, Inc.
2.91M
1.58%
-373.35K
-11.36%
Mar 31, 2025
MFS Investment Management
2.27M
1.23%
+5.83K
+0.26%
Mar 31, 2025
Genscript Biotech Corp
2.25M
1.22%
--
--
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
Harbor Health Care ETF
6.68%
Matthews Emerging Markets Discovery Active ETF
4.54%
Matthews Emerging Markets Sustainable Future Active ETF
4.48%
Global X Genomics & Biotechnology ETF
3.6%
Tema Oncology ETF
2.35%
Virtus LifeSci Biotech Products ETF
1.86%
KraneShares MSCI All China Health Care Index ETF
1.31%
iShares Biotechnology ETF
0.39%
ProShares Ultra Nasdaq Biotechnology
0.33%
iShares MSCI Emerging Markets Min Vol Factor ETF
0.29%
Ver Mais
Harbor Health Care ETF
Proporção6.68%
Matthews Emerging Markets Discovery Active ETF
Proporção4.54%
Matthews Emerging Markets Sustainable Future Active ETF
Proporção4.48%
Global X Genomics & Biotechnology ETF
Proporção3.6%
Tema Oncology ETF
Proporção2.35%
Virtus LifeSci Biotech Products ETF
Proporção1.86%
KraneShares MSCI All China Health Care Index ETF
Proporção1.31%
iShares Biotechnology ETF
Proporção0.39%
ProShares Ultra Nasdaq Biotechnology
Proporção0.33%
iShares MSCI Emerging Markets Min Vol Factor ETF
Proporção0.29%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
